496 related articles for article (PubMed ID: 15325574)
1. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
Ghosh AK; Hirasawa N; Niki H; Ohuchi K
J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat.
Song SJ; Chung H; Yu HG
Ophthalmic Res; 2008; 40(1):35-40. PubMed ID: 18032914
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
7. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
[TBL] [Abstract][Full Text] [Related]
9. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
Edelman JL; Castro MR; Wen Y
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat].
Zhao SH; He SZ; Shi XH
Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):522-7. PubMed ID: 15454039
[TBL] [Abstract][Full Text] [Related]
12. Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization.
Mwaikambo BR; Sennlaub F; Ong H; Chemtob S; Hardy P
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4356-64. PubMed ID: 17003426
[TBL] [Abstract][Full Text] [Related]
13. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
[TBL] [Abstract][Full Text] [Related]
14. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
Oka T; Shearer T; Azuma M
Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch.
Félétou M; Staczek J; Duhault J
Br J Pharmacol; 2001 Mar; 132(6):1342-8. PubMed ID: 11250886
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
